Marty Makary, Trump’s FDA commissioner, announces faster drug approval program
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency…
